Avidity Biosciences, Inc (RNAM) — Financial Flexibility Index
Avidity Biosciences, Inc (RNAM) has a Financial Flexibility Index of -0.61x as of December 2025. Free cash flow of $-164.26 Million (operating CF $-169.77 Million minus capex $5.51 Million) represents -1% of total liabilities ($269.45 Million). Also explore Avidity Biosciences, Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Avidity Biosciences, Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Avidity Biosciences, Inc across 8 annual periods. Check Avidity Biosciences, Inc (RNAM) asset resilience to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Avidity Biosciences, Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Avidity Biosciences, Inc. For the full company profile including market capitalisation, see Avidity Biosciences, Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.36x | $-637.12 Million | $-650.44 Million | $269.45 Million | ▼ -11.8% |
| 2024 | -2.11x | $-293.80 Million | $-300.87 Million | $138.94 Million | ▼ -135.3% |
| 2023 | -0.90x | $-114.84 Million | $-119.06 Million | $127.79 Million | ▲ +59.1% |
| 2022 | -2.20x | $-133.44 Million | $-136.27 Million | $60.73 Million | ▼ -11.4% |
| 2021 | -1.97x | $-91.07 Million | $-94.81 Million | $46.15 Million | ▼ -51.6% |
| 2020 | -1.30x | $-36.02 Million | $-37.12 Million | $27.68 Million | ▼ -7851.3% |
| 2019 | 0.02x | $2.73 Million | $2.49 Million | $162.26 Million | ▲ +107.9% |
| 2018 | -0.21x | $-9.61 Million | $-9.65 Million | $45.11 Million | — |